Analysis Article • May 01

Over the last 7 days, the Clinical Research and Equipment industry has risen 1.9%, driven by gains from AddLife of 2.4%. However, the industry is down 15% over the past year. Earnings are forecast to grow by 20% annually.
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 23 May 2026 | SEK 30.0b | SEK 14.6b | -SEK 850,163,077.00 | 37.7x | -35.3x | 2.1x |
| Mon, 20 Apr 2026 | SEK 31.3b | SEK 14.6b | -SEK 971,664,077.00 | 36.3x | -32.2x | 2.1x |
| Wed, 18 Mar 2026 | SEK 27.1b | SEK 14.6b | -SEK 838,374,077.00 | 32.7x | -32.3x | 1.9x |
| Fri, 13 Feb 2026 | SEK 26.7b | SEK 14.9b | -SEK 555,615,427.00 | 32.1x | -48.1x | 1.8x |
| Sun, 11 Jan 2026 | SEK 30.7b | SEK 14.9b | -SEK 744,515,427.00 | 48x | -41.3x | 2.1x |
| Tue, 09 Dec 2025 | SEK 33.0b | SEK 14.9b | -SEK 744,515,427.00 | 55.3x | -44.3x | 2.2x |
| Thu, 06 Nov 2025 | SEK 35.8b | SEK 14.7b | -SEK 742,825,012.00 | 52x | -48.3x | 2.4x |
| Sat, 04 Oct 2025 | SEK 34.5b | SEK 14.7b | SEK 61.3m | 58.7x | 562.8x | 2.4x |
| Mon, 01 Sep 2025 | SEK 34.9b | SEK 14.7b | SEK 60.9m | 58.4x | 573.9x | 2.4x |
| Wed, 30 Jul 2025 | SEK 36.6b | SEK 14.8b | SEK 186.0m | 61.8x | 196.6x | 2.5x |
| Fri, 27 Jun 2025 | SEK 45.9b | SEK 16.6b | SEK 405.8m | 70.1x | 113x | 2.8x |
| Sun, 25 May 2025 | SEK 45.0b | SEK 16.6b | SEK 401.6m | 68.5x | 112.1x | 2.7x |
| Tue, 22 Apr 2025 | SEK 36.9b | SEK 16.6b | SEK 609.4m | 39.6x | 60.5x | 2.2x |
| Thu, 20 Mar 2025 | SEK 37.6b | SEK 16.6b | SEK 614.9m | 38x | 61.1x | 2.3x |
| Sat, 15 Feb 2025 | SEK 43.7b | SEK 17.0b | -SEK 1,038,511,426.00 | 42.5x | -42.1x | 2.6x |
| Mon, 13 Jan 2025 | SEK 43.7b | SEK 16.7b | -SEK 1,152,911,426.00 | 49.5x | -37.9x | 2.6x |
| Wed, 11 Dec 2024 | SEK 44.2b | SEK 16.7b | -SEK 1,152,911,426.00 | 51.5x | -38.4x | 2.6x |
| Fri, 08 Nov 2024 | SEK 43.3b | SEK 16.8b | -SEK 958,019,827.00 | 50.4x | -45.2x | 2.6x |
| Sun, 06 Oct 2024 | SEK 47.2b | SEK 16.7b | -SEK 988,175,491.00 | 58.9x | -47.7x | 2.8x |
| Tue, 03 Sep 2024 | SEK 49.2b | SEK 16.7b | -SEK 987,374,492.00 | 62.7x | -49.8x | 2.9x |
| Thu, 01 Aug 2024 | SEK 50.4b | SEK 16.7b | -SEK 1,128,120,510.00 | 64x | -44.7x | 3x |
| Sat, 29 Jun 2024 | SEK 42.0b | SEK 16.3b | -SEK 1,188,686,510.00 | 55.3x | -35.3x | 2.6x |
| Mon, 27 May 2024 | SEK 42.2b | SEK 16.3b | -SEK 1,188,686,510.00 | 60.1x | -35.5x | 2.6x |
| Wed, 24 Apr 2024 | SEK 37.5b | SEK 16.0b | -SEK 1,122,732,213.00 | 35.9x | -33.4x | 2.3x |
| Fri, 22 Mar 2024 | SEK 39.4b | SEK 16.0b | -SEK 1,122,792,210.00 | 36.3x | -35.1x | 2.5x |
| Sun, 18 Feb 2024 | SEK 41.0b | SEK 16.0b | -SEK 1,409,735,350.00 | 50.7x | -29.1x | 2.6x |
| Tue, 16 Jan 2024 | SEK 37.0b | SEK 15.5b | -SEK 1,393,723,683.00 | 44.9x | -26.5x | 2.4x |
| Thu, 14 Dec 2023 | SEK 35.1b | SEK 15.5b | -SEK 1,393,723,683.00 | 42.4x | -25.2x | 2.3x |
| Sat, 11 Nov 2023 | SEK 31.2b | SEK 15.4b | -SEK 1,256,647,710.00 | 34x | -24.8x | 2x |
| Mon, 09 Oct 2023 | SEK 26.1b | SEK 15.1b | -SEK 1,134,516,711.00 | 36.2x | -23x | 1.7x |
| Wed, 06 Sep 2023 | SEK 30.0b | SEK 15.1b | -SEK 1,134,263,831.00 | 41x | -26.4x | 2x |
| Fri, 04 Aug 2023 | SEK 31.9b | SEK 15.1b | -SEK 213,871,038.00 | 46.3x | -149x | 2.1x |
| Sun, 02 Jul 2023 | SEK 36.5b | SEK 14.6b | -SEK 172,476,038.00 | 36.1x | -211.7x | 2.5x |
| Tue, 30 May 2023 | SEK 39.0b | SEK 14.6b | -SEK 173,602,038.00 | 38.3x | -224.7x | 2.7x |
-224.7x
How does Swedish Clinical Research and Equipment compare with similar industries?
| SE Market | 3.21% | |
| Healthcare | 3.69% | |
| Life Sciences | 4.06% | |
| Clinical Research and Equipment | 4.06% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALIF B AddLife | SEK 150.90 | 4.3% +SEK 755.6m | -15.2% | PE32.4x | |
| MCAP MedCap | SEK 565.50 | 4.6% +SEK 375.5m | 29.7% | PE37.7x | |
| BICO BICO Group | SEK 18.82 | 3.7% +SEK 48.0m | -48.3% | PS0.9x | |
| PRO Promimic | SEK 11.20 | 3.7% +SEK 7.6m | -36.9% | PS4.1x | |
| LEVBIO Level Bio | SEK 0.34 | 23.5% +SEK 4.4m | -24.7% | PS0.7x |